Trials / Completed
CompletedNCT01432392
Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
A Prospective, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the impact of gastroesophageal reflux disease (GERD) treatment in primary care setting on symptom control and daily life in symptomatic GERD patients, using both GERD questionnaire and clinical symptoms assessment
Detailed description
A prospective, observational study to describe symptom control and impact on daily life in patients with gastroesophageal reflux disease (GERD)
Conditions
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2011-09-13
- Last updated
- 2012-05-10
Locations
2 sites across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT01432392. Inclusion in this directory is not an endorsement.